Glipizide and Metformin HCl 250 mg/1

Glipizide and Metformin HCl 250 mg/1 is a combination medication used to manage type 2 diabetes. It helps control blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver. This oral tablet is suitable for adults with diabetes who require dual therapy.

Glipizide and Metformin HCl 250 mg/1 is primarily used to manage type 2 diabetes in adults. It combines two active ingredients: Glipizide, which stimulates the pancreas to produce more insulin, and Metformin, which reduces the amount of sugar released by the liver and improves the body's response to insulin. This medication is often prescribed when diet and exercise alone are not enough to control blood sugar levels. It is important to follow the advice of a healthcare provider when using this medication.

Common effects of Glipizide and Metformin HCl 250 mg/1 may include nausea, diarrhea, and stomach upset. Some individuals may experience low blood sugar (hypoglycemia), especially when combined with other diabetes medications or insulin. It is important to monitor blood sugar levels regularly and report any severe or persistent side effects to a healthcare provider.

Glipizide and Metformin HCl 250 mg/1 should be used with caution in individuals with kidney or liver problems. It is important to inform a healthcare provider about any medical conditions or allergies before starting this medication. Regular monitoring of blood sugar levels and kidney function is recommended. This medication should be stored at room temperature, away from moisture and heat.

Glipizide and Metformin HCl 250 mg/1 may interact with other medications, including certain antibiotics, diuretics, and other diabetes medications. Alcohol consumption should be avoided as it can increase the risk of low blood sugar and lactic acidosis. It is important to inform a healthcare provider about all medications, including over-the-counter drugs and supplements, before starting this medication.